Perceptive Advisors SDGR Position
ActivePerceptive Advisors initiated a new position in Schrodinger Inc. (SDGR) in Q4 2025, holding $3.6M worth of shares across 202,400 shares.
1 other tracked fund also holds SDGR.
Short interest stands at 27.9% of float with 7.9 days to cover, indicating significant bearish positioning against Perceptive's long thesis.
About Schrodinger Inc.
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Full company profile →Short Interest
27.9%
7.9 days to cover
Frequently Asked Questions
Does Perceptive Advisors own SDGR?
Yes. As of Q4 2025, Perceptive Advisors holds 202,400 shares of Schrodinger Inc. (SDGR) valued at $3.6M. This data comes from their SEC 13F filing.
How many hedge funds own SDGR?
2 specialist biotech hedge funds currently hold SDGR, including Deerfield Management. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Perceptive Advisors first buy SDGR?
Perceptive Advisors's position in SDGR was first reported in Q4 2025. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Perceptive Advisors's SDGR position increasing or decreasing?
Perceptive Advisors initiated a new position in SDGR in the most recent quarter. This is their first reported holding.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
SDGRCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Perceptive AdvisorsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →